Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 7Small Cell Lung Carcinoma 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Neoplasm Metastasis 1Motor Activity 1Melanoma 1Gastrointestinal Neoplasms 1Fibrosis 1Cognitive Dysfunction 1Central Nervous System Carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2enfortumab vedotin 2Tablets 2Exercise 2Acupuncture Therapy 2nicotinamide-beta-riboside 1Vitamin B Complex 1Thioctic Acid 1Tadalafil 1Single Person 1Rosuvastatin Calcium 1Omeprazole 1Memantine 1Massage 1Lenalidomide 1Gloves, Surgical 1Fish Oils 1Fenofibrate 1Exercise Therapy 1Dexamethasone 1Cryotherapy 1Corn Oil 1Control Groups 1Bortezomib 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Memantine × 1 year × Clear all
NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡